KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial.

J Clin Oncol · 2026-Jan-20 · PMID 41365333

Panel B_4提取失败待 EXE 对齐验证

DFS

FIG A3. Kaplan-Meier plot of DFS curve stratified by (A) age at diagnosis and (B) HER2 status. HER2-low indicated tumors with HER2 IHC status 1+ to 2+. Cb, carboplatin; DFS, disease-free survival; EC-T, epirubicin plus cyclophosphamide followed by taxanes; EC-TCb, EC-T plus carboplatin; HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.16
质量通过否
预期曲线2
实际曲线0
X 范围-1 – 9.5
Y 范围0 – 0.75
No curves extracted

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0failed待验证02026-07-23T17:06:25+00:00